VivoSeq
Other

Aspiration

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Aspiration is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

33/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed5 · 33%
Unknown status3 · 20%
Terminated3 · 20%
Withdrawn2 · 13%
Recruiting1 · 7%
Active, not recruiting1 · 7%

Trial Activity

15 trials

Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration
Completed··Phase 4·NCT01495377·25 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)